← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:76 | 76 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | 7-Keto-Dehydroepiandrosterone; Estradiol; Testosterone; Progesterone | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:76 | 76 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:76 | 76 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-204 | 70713-204-06 | Alprostadil; Phentolamine Mesylate; Papaverine Hydrochloride; Atropine Sulfate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:76 | 76 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-728 | 72833-728-30 | Aminohippuric Acid | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:76 | 76 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0440 | 70168-0440-1 | Anastrozole | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:76 | 76 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0754 | 73271-0754-1 | Anastrozole; Testosterone | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:76 | 76 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-016 | 79926-016-04 | Apomorphine Hydrochloride | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:76 | 76 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8264 | 72682-8264-1 | Anastrozole; Testosterone | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:76 | 76 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:76 | 76 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0440 | 70168-0440-1 | Anastrozole | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:76 | 76 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-7272 | 72682-7272-1 | Ascorbic Acid | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:76 | 76 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:76 | 76 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5001 | 26436-5001-5 | Ascorbic Acid | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:76 | 76 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2025-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2026-1:76 | 76 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2026-1 | source_no_ndc | 1 | 2026-10-13 | |||
compounder:77 | 77 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1591 | 72934-1591-2 | Aluxof | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:77 | 77 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Acetaminophen | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:77 | 77 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:77 | 77 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-204 | 70713-204-05 | Alprostadil; Phentolamine Mesylate; Papaverine Hydrochloride; Atropine Sulfate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:77 | 77 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:77 | 77 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0410 | 70168-0410-1 | Anastrozole | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:77 | 77 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:77 | 77 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-015 | 79926-015-04 | Apomorphine Hydrochloride | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:77 | 77 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8218 | 72682-8218-1 | Anastrozole; Testosterone | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:77 | 77 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-004 | 70092-004-37 | Amiodarone | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:77 | 77 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1004 | 73271-1004-1 | Anastrozole; 1-Testosterone | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:77 | 77 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-4125 | 72682-4125-1 | Ascorbic Acid | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:77 | 77 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:77 | 77 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2025-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-2:77 | 77 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-7272 | 72682-7272-1 | Ascorbic Acid | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:77 | 77 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2026-1 | source_no_ndc | 1 | 2026-10-13 | |||
compounder:78 | 78 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-007 | 70713-007-01 | TESTOSTERONE SA2 87.5MG | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:78 | 78 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Acetaminophen | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:78 | 78 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:78 | 78 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-201 | 70713-201-06 | Alprostadil; Phentolamine Mesylate; Papaverine Hydrochloride; Atropine Sulfate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:78 | 78 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:78 | 78 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:78 | 78 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:78 | 78 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Arginine | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:78 | 78 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0620 | 70168-0620-1 | Anastrozole; Testosterone Cypionate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:78 | 78 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-005 | 70092-005-38 | Amiodarone | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:78 | 78 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0754 | 73271-0754-1 | Anastrozole; Testosterone | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:78 | 78 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-2243 | 72682-2243-1 | Ascorbic Acid | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:78 | 78 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-036 | 71506-036-01 | Atropine Sulfate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:78 | 78 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2025-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-2:78 | 78 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5001 | 26436-5001-5 | Ascorbic Acid | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:78 | 78 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5213 | 26436-5213-5 | Ascorbic Acid | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:79 | 79 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5594 | 26436-5594-3 | B12 MIC | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:79 | 79 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Acetaminophen | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:79 | 79 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:79 | 79 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-201 | 70713-201-05 | Alprostadil; Phentolamine Mesylate; Papaverine Hydrochloride; Atropine Sulfate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:79 | 79 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0430 | 70168-0430-1 | Anastrozole | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:79 | 79 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:79 | 79 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:79 | 79 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2414 | 72627-2414-1 | Arginine Hydrochloride | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:79 | 79 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0610 | 70168-0610-1 | Anastrozole; Testosterone Cypionate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:79 | 79 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:79 | 79 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8218 | 72682-8218-1 | Anastrozole; Testosterone | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:79 | 79 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atorvastatin Calcium Trihydrate | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:79 | 79 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:79 | 79 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0001 | 71285-0001-1 | Aspartic Acid; Glutamic Acid | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:79 | 79 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0001 | 71285-0001-1 | Aspartic Acid; Glutamic Acid | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:79 | 79 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5001 | 26436-5001-5 | Ascorbic Acid | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:80 | 80 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7039 | 71285-7039-1 | Phenylephrine 50mg added to NS | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:80 | 80 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Acetaminophen | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:80 | 80 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:80 | 80 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-203 | 70713-203-06 | Alprostadil; Phentolamine Mesylate; Papaverine Hydrochloride; Atropine Sulfate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:80 | 80 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0440 | 70168-0440-1 | Anastrozole | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:80 | 80 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:80 | 80 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:80 | 80 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-636 | 72833-636-30 | Arginine Hydrochloride | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:80 | 80 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-016 | 79926-016-04 | Apomorphine Hydrochloride | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:80 | 80 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:80 | 80 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8264 | 72682-8264-1 | Anastrozole; Testosterone | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:80 | 80 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atorvastatin Calcium Trihydrate | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:80 | 80 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-229 | 70092-229-43 | Atropine Sulfate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:80 | 80 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-036 | 71506-036-01 | Atropine Sulfate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:80 | 80 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atorvastatin Calcium Trihydrate | 2025-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2026-1:80 | 80 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0001 | 71285-0001-1 | Aspartic Acid; Glutamic Acid | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:81 | 81 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-1012 | 79559-1012-1 | S-T012.5 | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:81 | 81 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Acetylcysteine | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:81 | 81 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5037 | 26436-5037-1 | Alprostadil; Papaverine Hydrobromide; Phentolamine Mesylate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:81 | 81 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-203 | 70713-203-05 | Alprostadil; Phentolamine Mesylate; Papaverine Hydrochloride; Atropine Sulfate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:81 | 81 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0410 | 70168-0410-1 | Anastrozole | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:81 | 81 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:81 | 81 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:81 | 81 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2405 | 72627-2405-1 | Ascorbic Acid | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:81 | 81 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-015 | 79926-015-04 | Apomorphine Hydrochloride | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:81 | 81 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:81 | 81 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8215 | 72682-8215-1 | Anastrozole; Testosterone | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:81 | 81 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:81 | 81 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9010 | 83826-9010-3 | Atropine Sulfate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:81 | 81 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9010 | 83826-9010-3 | Atropine Sulfate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:81 | 81 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atorvastatin Calcium Trihydrate | 2025-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2026-1:81 | 81 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atorvastatin Calcium Trihydrate | 2026-1 | source_no_ndc | 1 | 2026-10-13 | |||
compounder:82 | 82 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5044 | 26436-5044-3 | Procaine 2% | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:82 | 82 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Acetylcysteine | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:82 | 82 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5037 | 26436-5037-5 | Alprostadil; Papaverine Hydrobromide; Phentolamine Mesylate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:82 | 82 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-202 | 70713-202-06 | Alprostadil; Phentolamine Mesylate; Papaverine Hydrochloride; Atropine Sulfate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:82 | 82 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1004 | 73271-1004-1 | Anastrozole; 1-Testosterone | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:82 | 82 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:82 | 82 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0620 | 70168-0620-1 | Anastrozole; Testosterone Cypionate | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:82 | 82 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:82 | 82 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-069 | 73198-069-30 | Arginine | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:82 | 82 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:82 | 82 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8214 | 72682-8214-1 | Anastrozole; Testosterone | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:82 | 82 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-308 | 83298-308-03 | Atropine Sulfate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:82 | 82 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9011 | 83826-9011-3 | Atropine Sulfate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:82 | 82 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9011 | 83826-9011-3 | Atropine Sulfate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:82 | 82 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-036 | 71506-036-01 | Atropine Sulfate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:82 | 82 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2026-1 | source_no_ndc | 1 | 2026-10-13 | |||
compounder:83 | 83 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-029 | 71506-029-58 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:83 | 83 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Acyclovir; Lidocaine | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:83 | 83 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-216 | 70713-216-05 | Alprostadil; Phentolamine Mesylate; Papaverine Hydrochloride | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:83 | 83 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:83 | 83 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0754 | 73271-0754-1 | Anastrozole; Testosterone | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:83 | 83 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0620 | 70168-0620-1 | Anastrozole; Testosterone Cypionate | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:83 | 83 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0610 | 70168-0610-1 | Anastrozole; Testosterone Cypionate | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:83 | 83 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:83 | 83 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2414 | 72627-2414-1 | Arginine Hydrochloride | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:83 | 83 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:83 | 83 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8274 | 72682-8274-1 | Anastrozole; Testosterone | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:83 | 83 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-036 | 71506-036-01 | Atropine Sulfate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:83 | 83 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-122 | 73177-122-01 | Atropine Sulfate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:83 | 83 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-122 | 73177-122-01 | Atropine Sulfate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:83 | 83 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9012 | 83826-9012-3 | Atropine Sulfate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:83 | 83 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-036 | 71506-036-01 | Atropine Sulfate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:84 | 84 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-3 | Hydromorphone HCl | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:84 | 84 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0200 | 71285-0200-1 | Adenosine; Sodium Chloride; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:84 | 84 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-207 | 70713-207-05 | Alprostadil; Phentolamine Mesylate; Papaverine Hydrochloride | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:84 | 84 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:84 | 84 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:84 | 84 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0610 | 70168-0610-1 | Anastrozole; Testosterone Cypionate | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:84 | 84 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Apomorphine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:84 | 84 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:84 | 84 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2404 | 72627-2404-1 | Ascorbic Acid | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:84 | 84 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5483 | 26436-5483-1 | Amphotericin B; Chloramphenicol | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:84 | 84 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0620 | 70168-0620-1 | Anastrozole; Testosterone Cypionate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:84 | 84 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:84 | 84 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9012 | 83826-9012-3 | Atropine Sulfate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:84 | 84 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-229 | 70092-229-43 | Atropine Sulfate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:84 | 84 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-229 | 70092-229-43 | Atropine Sulfate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:84 | 84 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2026-1 | source_no_ndc | 1 | 2026-10-13 | |||
compounder:85 | 85 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1585 | 72934-1585-2 | Aphoria | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:85 | 85 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Aflibercept | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:85 | 85 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-205 | 70713-205-05 | Alprostadil; Phentolamine Mesylate; Papaverine Hydrochloride; Atropine Sulfate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:85 | 85 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amlodipine Besylate | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:85 | 85 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:85 | 85 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Apomorphine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:85 | 85 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-016 | 79926-016-04 | Apomorphine Hydrochloride | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:85 | 85 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:85 | 85 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-7272 | 72682-7272-3 | Ascorbic Acid | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:85 | 85 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5484 | 26436-5484-1 | Amphotericin B; Clioquinol | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:85 | 85 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0610 | 70168-0610-1 | Anastrozole; Testosterone Cypionate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:85 | 85 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9010 | 83826-9010-3 | Atropine Sulfate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:85 | 85 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-508 | 65302-508-35 | Atropine Sulfate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:85 | 85 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2025-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-2:85 | 85 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-1 | Atropine Sulfate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:85 | 85 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2026-1 | source_no_ndc | 1 | 2026-10-13 | |||
compounder:86 | 86 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0724 | 26436-0724-9 | Naltrexone 2 | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:86 | 86 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Aflibercept | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:86 | 86 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-204 | 70713-204-05 | Alprostadil; Phentolamine Mesylate; Papaverine Hydrochloride; Atropine Sulfate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:86 | 86 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amlodipine Besylate | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:86 | 86 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:86 | 86 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Apomorphine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:86 | 86 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-015 | 79926-015-04 | Apomorphine Hydrochloride | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:86 | 86 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2404 | 72627-2404-1 | Ascorbic Acid | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:86 | 86 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:86 | 86 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5482 | 26436-5482-1 | Amphotericin B; Sulfamethoxazole; Chloramphenicol | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:86 | 86 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5111 | 26436-5111-3 | Arginine | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:86 | 86 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9011 | 83826-9011-3 | Atropine Sulfate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:86 | 86 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:86 | 86 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9012 | 83826-9012-3 | Atropine Sulfate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:86 | 86 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9010 | 83826-9010-3 | Atropine Sulfate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:86 | 86 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9010 | 83826-9010-3 | Atropine Sulfate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:87 | 87 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-740 | 69194-740-01 | 740 LIDOCAINE HCl 4% BOTTLE | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:87 | 87 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Alprostadil | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:87 | 87 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-203 | 70713-203-05 | Alprostadil; Phentolamine Mesylate; Papaverine Hydrochloride; Atropine Sulfate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:87 | 87 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0430 | 70168-0430-1 | Anastrozole | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:87 | 87 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:87 | 87 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-016 | 79926-016-04 | Apomorphine Hydrochloride | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:87 | 87 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Apomorphine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:87 | 87 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-690 | 72833-690-50 | Ascorbic Acid | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:87 | 87 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:87 | 87 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0430 | 70168-0430-1 | Anastrozole | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:87 | 87 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5021 | 26436-5021-3 | Arginine | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:87 | 87 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:87 | 87 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:87 | 87 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-1 | Atropine Sulfate | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:87 | 87 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9011 | 83826-9011-3 | Atropine Sulfate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:87 | 87 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9011 | 83826-9011-3 | Atropine Sulfate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:88 | 88 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-015 | 73198-015-10 | RE-1 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:88 | 88 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Alprostadil | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:88 | 88 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-202 | 70713-202-05 | Alprostadil; Phentolamine Mesylate; Papaverine Hydrochloride; Atropine Sulfate | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:88 | 88 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0440 | 70168-0440-1 | Anastrozole | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:88 | 88 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:88 | 88 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-015 | 79926-015-04 | Apomorphine Hydrochloride | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:88 | 88 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-787 | 72833-787-04 | Arginine | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:88 | 88 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-7272 | 72682-7272-3 | Ascorbic Acid | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:88 | 88 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2022-2 | source_no_ndc | 1 | 2026-10-13 |